Swedish oncology firm Elekta said it has received CE Mark clearance for its Fraxion patient-specific cranial immobilization system.
The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy of cancer targets in the brain and cranium, according to the Stockholm-based firm.
Partial and full-head thermoplastic masks provide alternative immobilization options for noninvasive setup, without compromising accuracy. Combining the thermoplastic mask with the vacuum mouthpiece increases flexibility in setup options, allowing optimal setup based on the patient's needs, Elekta said.
Fraxion also features a target positioner, which provides accurate target localization for stereotactic planning, imaging, and treatment.
Related Reading
Calypso, Elekta to integrate technologies, December 16, 2010
Elekta sells stake in component firm, December 15, 2010
Elekta, Toshiba team up in Japan, December 10, 2010
Elekta nets FDA OK for XiO, December 3, 2010
Elekta adds to Mosaiq software, November 3, 2010
Copyright © 2011 AuntMinnie.com
